Surveys

In the wake of the VIOXX withdrawal, critics have suggested that FDA needs to reform how it regulates the drug industry. Many suggestions for reform have been suggested. We present a few of them here. Let us know what you think of these suggestions or if the FDA requires no reform at all!

Recently, pharma companies appear to be using more patient testimonials in their DTC (direct-to-consumer) broadcast and social media advertising. This survey asks your opinion of this practice, including what the benefits may be, the regulatory issues, and how it may evolve, especially with regard to use of social media.

This survey is designed to inform the discussion on the pros and cons of how Social, Mobile, & Gaming Technologies technologies drive patient engagement and what value they have in solving the long-standing medication adherence problem.

For pharmaceutical manufacturers, ePrescribing may offer a new channel to influence physician prescribing at the point of care.

This survey asks YOUR opinion about the privacy issues raised in a brief filed with the FTC regarding the online marketing practices of pharmaceutical and other health-related companies.

Please take 2 minutes to answer this survey relating to pharma-sponsored medical journal article ghostwriting.

By filling out the Pharma Marketing News Rate Your Social Media Marketing Readiness online questionnaire, you will discover where you may need to augment your knowledge about social media and what internal regulatory and cultural hurdles you may need to overcome to implement a social media marketing program.

Which of five future scenarios -- Triumph of Reason, Big Brother Arrives, Consumer Chaos, Safety Net, PhRMA's Platform -- is likely to unfold in the next 10 years and which one would benefit the pharmaceutical industry the most?

As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, and physicians) to post comments as part of ongoing discussions about drugs and/or the conditions they treat. Recent pharma experience with social media discussions demonstrate how important it is to properly manage online communities. Perhaps the most important management tool is moderation.

This survey solicited opinions on regulatory issues regarding Rx drug and device promotion via the Internet in general and social media in particular.